СПИСОК ЛИТЕРАТУРЫ

1. Stewart B.W., Wild C.P. World cancer report. Lyon: IARC, 2014. 916p.

2. Kurman R.J., Cargangiu M.L., Herrington C.S. et al. IAR Lion 2014. WHO Classification of female reproductive organs].

3. Франк Г.А., Москвина Л.В., Андреева Ю.Ю. Новая классификация опухолей яичника Журнал: Архив патологии. 2015; 77(4): 40 - 50. DOI: 10.17116/pato1201577440-50

4. Clark-Pearson D., Soper J. Gynecological Cancer Management. Identification, diagnosis and treatment. 2010. 196p.

5. Нейштадт Э.Л., Ожиганова И.Н. Опухоли яичника. - СПб: ООО "Издательство ФОЛИАНТ", 2014. - 352 с.: ил.

6. Клиническая онкогинекология: в 3 т./ под ред. Ф.Дж. Дисаи, У.Т. Крисмана; пер с англ. под ред. Е.Г. Новиковой. - М.: Практическая медицина, 2012. - Т.3. -с.: ил.

7. Ribic-Pucelj M., Kobal B., et al. Surgical treatment of adnexal masses in pregnancy. J Reprod Med 2007; 52: 273 - 279.

8. Hess C.U., Peaseman A., O'Brier W.F. et al. Adnexal masses occurring with intrauterine pregnancy: report of 54 patients requiring laparotomy for mature management. Am J ObstatGynacol. 1988; 93: 585 - 589.

9. Graham L. ACOG Releases Guidelines on Management of Adnexal Masses. Am Fam Physician 2008; 77(9): 1320 - 3.

10. Management of Suspected Ovarian Masses in Premenopausal Women. RCOG/BSGE Joint Green-top Guideline No. 62, Nov 2011.

11. The Management of Ovarian Cysts in Postmenopausal Women. RCOG Green-top Guideline No. 34, July 2016.

12. Colombo N, Peiretti M, Garbi A, et al. Non-Epithelial Ovarian Cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012; 23(7): vii20-6.

13. Peccatori FA, Azim HA Jr, Orecchia R, Hoekstra HJ, Pavlidis N, Kesic V, Pentheroudakis G. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol2013; 24(6): vii 160-70.

14. Guidelines for the Use of Laparoscopy for during Pregnancy. SAGES May 2017.

15. Prat J. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. FIGO Committee on Gynecologic Oncology. Int J GynecolObstet 2014; 124(1): 1 - 5.

16. The Role of the Obstetrician-Gynecologist in the Early Detection of Epithelial Ovarian Cancer in Women at Average Risk. ACOG Committee Opinion. SGO No.716, Nov 2017.

17. Ovarian Cancer Screening Tests: Safety Communication - FDA Recommends Against Use. U.S.FDA, Posted 09.07.2016.

18. Final Recommendation Statement: Ovarian Cancer: Screening. U.S. Preventive Services Task Force (USPSTF). December 2016.

19. Клинические рекомендации по диагностике и лечению больных раком яичников, маточной трубы или первичным раком брюшины. Ассоциация онкологов России, 2014.

20. ICD-Q International Classification of Diseases for Oncology. 3rd Edition. By Percy C.WHO 2000, 240 p.

21. Порядок оказания медицинской помощи по профилю "акушерство и гинекология" (за исключением использования вспомогательных репродуктивных технологий)", утвержденный приказом Минздрава России от 1 ноября 2012 г. N 572н (ред. от 12 января 2016 г.) и зарегистрированный в Минюсте России 2 апреля 2013 г. N 27960.

22. Karseladze AI. WHO histological classification of ovarian tumors. Geneva 1999. ArkhPatol 2005; 1:64.

23. Randall LM, Pothuri B, Swisher EM. Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper. GynOncol 2017; 146: 217-24.

24. Rizzuto I, Behrens RF, Smith LA. Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility (Review). Cochrane Database Syst Rev 2013, Issue 8.

25. Bunyavejchevin S, Phupong V. Laparoscopic surgery for presumed benign ovarian tumor during pregnancy. Cochrane Database Syst Rev 2013, Jan 31(1).

26. Новикова Е.Г., Чиссов В.И., Чулкова О.В. и др. Органосохраняющее лечение в онкогинекологии, Москва, 2000, 108 с.

27. Gotlieb WH, Chetrit A, Menczer J, et al. Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer. GynecolOncol 2005; 97(3): 780.

28. Stiekema A, Boldingh QJ, Korse CM, et al. Serum human epididymal protein 4 (HE4) as biomarker for the differentiation between epithelial ovarian cancer and ovarian metastases of gastrointestinal origin. GynecolOncol 2015; 136(3): 562-6.

29. Moore RG, Miller MC, Eklund EE, Lu KH, Bast RC, Lambert-Messerlian G. Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age. Am J ObstetGynecol 2012; 206(4): 349.

30. Santotoribio JD, Garcia-de 1a Torre A, Canavate-Solano C, et al. Cancer antigens 19.9 and 125 as tumor markers in patients with mucinous ovarian tumors. Eur J GynaecolOncol 2016; 37(1): 26-9.

31. Клиническая онкогинекология. Руководство для врачей. Под ред. В.П. Козаченко, Москва, 2016, 250 стр.

32. Fagotti A, Perelli F, Pedone L, Scambia G. Current Recommendations for Minimally Invasive Surgical Staging in Ovarian Cancer. Curr Treat Options Oncol 2016; 17(1): 3.

33. Мартынов С.А., Хирургическая тактика при лечении беременных с опухолевидными образованиями и опухолями яичников// Дис. д.м.н. 2016, 165 с.

34. Recent Advances in Diagnosis and Management of Ovarian Cancer. Jensen, S. E., & S.A., F. (Ed.) -First Edition. U.S.A.: Springer. 2014.

35. Герфанова Е.В., Ашрафян Л.А., Антонова И.Б., Алешикова О.И., Ивашина С.В. Опухоли женской репродуктивной системы. 2015, 1: 70 - 75.

36. Hart WR. Borderline epithelial tumors of the ovary. Mod Pathol 2005; 18(Suppl2):S33-50.

37. Jones MB. Borderline ovarian tumors: current concepts for prognostic factors and clinical management. ClinObstetGynecol 2006: 49:517.

38. McDonald JM. Modesitt SC. The incidental postmenopausal adnexal mass. ClinObstetGvnecol. 2006 Sep; 49(3): 506-16.

39. Hereditary breast and ovarian cancer syndrome. ACOG Practice Bulletin No. 103. ObstetGynecol 2009; 113: 957-66.

40. Morgan RJ, Armstrong DK, Alvarez RD, et al. Ovarian Cancer, Version 1.2016. NCCN Clinical practice guidelines in oncology. J Nat Comp Cancer Network 2016; 14(9): 1134-63.

41. Порядок проведения диспансеризации определенных групп взрослого населения в редакции приказа Минздрава России от 9 декабря 2016 г. N 946н "О внесении изменений в порядок проведения диспансеризации определенных групп взрослого населения, утвержденному приказом Минздрава России от 3 февраля 2015 г. N 36ан"

42. Kurman R.J. et al. Blaustein's Pathology of the Female Genital Tract 6th edition. - Springer, 2011.

43. Акушерство. Национальное руководство. М.: ГЭОТАР-Медиа, 2015. - 1080 с.

44. Brown DL, Andreotti RF, Lee SI, et al. ACR appropriateness criteria ovarian cancer screening. Ultrasound Q. 2010; 26(4): 219-23.

45. Timmerman D, Van Calster B, Testa AC et al. Ovarian cancer prediction in adnexal masses using ultrasound-based logistic regression models: a temporal and external validation study by the IOTA group. Ultrasound ObstetGynecol 2010; 36: 226 - 234.

46. Timmerman DV, L.; Bourne, T.H.; Collins, W.P.; Verrelst H.; Vergote, I. Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) group. UltrasondObstetGynecol 2000; 16: 500 - 505.

47. Jacobs I, Oram D, Fairbanks J et al. A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J ObstetGynaecol 1990; 97: 922 - 929.

48. Tingulstad S, Hagen B, Skjeldestad FE et al. The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals. ObstetGynecol 1999; 93: 448 - 452

49. Yen and Jaffe's reproductive endocrinology: physiology, pathophysiology, and clinical management/[edited by] Jerome F. Strauss III, Robert Barbieri. - 7thed.

50. Ovarian cancer: recognition and initial management. Clinical guideline. Published: 27 April 2011 nice.org.uk/guidance/cgl22 (https://www.nice.org.Uk/terms-and-conditions#notice-ofrights).

51. British Gynaecological Cancer Society (BGCS) Epithelial Ovarian/Fallopian Tube/Primary Peritoneal Cancer Guidelines: Recommendations for Practice.2017.P.48.

52. Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement. US Preventive Services Task Force. Grossman DC, Curry SJ, Owens DK, Barry MJ, Davidson KW, Doubeni CA, Epling JW Jr, Kemper AR, Krist AH, Kurth AE, Landefeld CS, Mangione CM, Phipps MG, Silverstein M, Simon MA, Tseng CW. JAMA. 2018 Feb 13; 319(6): 588 - 594.

53. Screening for Ovarian Cancer. Jin J. JAMA. 2018 Feb 13; 319(6):624. doi: 10.1001 /jama.2017.22136.

54. Приказ Минздрава России от 10 мая 2017 N 203н "Об утверждении критериев оценки качества медицинской помощи" (зарегистрировано в Минюсте России 17 мая 2017 г. N 46740)